maravai lifesciences holdings glp-1 receptor agonist medications Harnessing Agonists for Obesity Treatment: Prospects and Obstacles on the Horizon GLP-1 Receptor Agonist Market Size
Description
Natures GLP-1
At least, not yet
In 1929 they published a landmark review of ten investigations into the effect of secretin on blood glucose levels which had reported contradictory results
These results give us a direction that GLP-1RAs, currently used for diabetes, may be an alternative drug for the treatment of osteoporosis
